HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia

Leukemia Research

Volumn 35, Issue 10, 2011, Pages 1350-1354

  Guo, Q Y ^a   Chen, B G ^a   Ruan, Y Y ^a   Lin, A ^a   Yan, W H ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Acute myeloid leukemia; HLA G; Prognosis

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; HLA G ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER SURVIVAL; CHILD; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL TIME; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ANTIGENS, CD45; CHILD; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HLA-G ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 80052079060     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.05.036     Document Type: Article

References (38)

1. Carosella E.D., Moreau P., Lemaoult J., et al. HLA-G: from biology to clinical benefits. Trends Immunol 2008, 29:125-132.
2. Paul P., Cabestre F.A., Ibrahim E.C., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000, 61:1138-1149.
3. Pistoia V., Morandi F., Wang X., et al. Soluble HLA-G: are they clinically relevant?. Semin Cancer Biol 2007, 17:469-479.
4. Naji A., Le Rond S., Durrbach A., et al. CD3+CD4 low and CD3+CD8 low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 2007, 110:3936-3948.
5. LeMaoult J., Krawice-Radanne I., Dausset J., et al. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004, 101:7064-7069.
6. LeMaoult J., Caumartin J., Daouya M., et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007, 109:2040-2048.
7. Liang S., Horuzsko A. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 2003, 64:1025-1032.
8. Selmani Z., Naji A., Zidi I., et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25 highFOXP3+ regulatory T cells. Stem Cells 2008, 26:212-222.
9. Caumartin J., Favier B., Daouya M., et al. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007, 26:1423-1433.
10. Giuliani M., Giron-Michel J., Negrini S., et al. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS One 2008, 3:e2241.
11. Wiendl H., Mitsdoerffer M., Hofmeister V., et al. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002, 168:4772-4780.
12. Carosella E.D., HoWangYin K.Y., Favier B., et al. HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Hum Immunol 2008, 69:700-707.
13. Kovats S., Main E.K., Librach C., et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
14. Mallet V., Blaschitz A., Crisa L., et al. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol 1999, 11:889-898.
15. Le Discorde M., Moreau P., Sabatier P., et al. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003, 64:1039-1044.
16. Ito T., Ito N., Saathoff M., et al. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 2005, 125:1139-1148.
17. Cirulli V., Zalatan J., McMaster M., et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006, 55:1214-1222.
18. Paul P., Rouas-Freiss N., Khalil-Daher I., et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998, 95:4510-4515.
19. Rouas-Freiss N., Moreau P., Ferrone S., et al. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?. Cancer Res 2005, 65:10139-10144.
20. Urosevic M., Dummer R. Human leukocyte antigen-G and cancer immunoediting. Cancer Res 2008, 68:627-630.
21. Nückel H., Rebmann V., Dürig J., et al. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005, 105:1694-1698.
22. Perez-Chacon G., Rosado S., Rebolleda N., et al. Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia. Int J Lab Hematol 2009, 31:327-337.
23. Giannopoulos K., Dmoszyńska A., Bojarska-Junak A., et al. Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL). Folia Histochem Cytobiol 2008, 46:457-460.
24. Maki G., Hayes G.M., Naji A., et al. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia 2008, 22:998-1006.
25. Yan W.H., Lin A., Chen B.G., et al. Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia. J Cell Mol Med 2008, 12:889-898.
26. Gros F., Sebti Y., de Guibert S., et al. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 2006, 8:223-230.
27. Lacombe F., Durrieu F., Briais A., et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 1997, 11:1878-1886.
28. Rizzo R., Melchiorri L., Stignani M., et al. HLA-G expression is a fundamental prerequisite to pregnancy. Hum Immunol 2007, 68:244-250.
29. Lin A., Zhang X., Zhou W.J., et al. HLA-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Cancer 2010, 10.1002/ijc.25807.
30. Yoon B.S., Kim Y.T., Kim J.W., et al. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet 2007, 98:48-53.
31. Adithi M., Kandalam M., Ramkumar H.L., Subramanian A., Venkatesan N., Krishnakumar S. Retinoblastoma: expression of HLA-G. Ocul Immunol Inflamm 2006, 14:207-213.
32. Lin A., Yan W.H., Xu H.H., et al. HLA-G expression in human ovarian carcinoma counteracts NK cell function. Ann Oncol 2007, 18:1804-1809.
33. Yie S.M., Yang H., Ye S.R., et al. Expression of human leukocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 2007, 58:267-274.
34. Ye S.R., Yang H., Li K., et al. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007, 20:375-383.
35. Yie S.M., Yang H., Ye S.R., et al. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007, 14:2721-2729.
36. Mizuno S., Emi N., Kasai M., et al. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia. Br J Haematol 2000, 111:280-282.
37. Poláková K., Krcová M., Kuba D., et al. Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients. Leuk Res 2003, 27:643-648.
38. Polakova K., Bandzuchova E., Sabty F.A., et al. Activation of HLA-G expression by 5-aza-2-deoxycytidine in malignant hematopoetic cells isolated from leukemia patients. Neoplasma 2009, 56:514-520.